Keyphrases
Ability to Act
14%
Anthracyclines
14%
Anthracyclins
28%
Breast Cancer Resistance Protein
14%
Cancer Cells
14%
Clinical Response
14%
Clinical Significance
14%
Clinical Survival
14%
Cytotoxic Drugs
14%
Defense Mechanisms
14%
Drug Resistance Profiles
14%
Drug Transport
28%
Energy-dependent
14%
Epipodophyllotoxin
14%
Epitope
14%
Intracellular Concentration
14%
Leukemia
100%
Leukemia Patients
14%
Long-term Survival
28%
Membrane Transport
100%
Membrane-associated
14%
MRP3
14%
Mrp4
14%
MRP5
14%
MRP6
14%
Multidrug Resistance
14%
Multidrug Resistance Protein
100%
Multidrug Resistance Protein 1 (MDR1)
100%
Multidrug Resistance-associated Protein 2 (MRP2)
14%
Multiple Relapses
14%
Non-associated
14%
Outcome Prediction
14%
Overexpression
28%
P-glycoprotein (P-gp)
42%
Predictive Value
14%
Presentation Time
14%
Prognostic Significance
100%
Prognostic Value
14%
Resistance Development
14%
Resistance Mechanisms
14%
Resistance Protein
14%
Sequestration
14%
Strong Correlation
14%
TAP1
14%
Transmembrane
14%
Transmembrane Protein
14%
Transport Proteins
28%
Vinca Alkaloids
14%
Working Diagnosis
57%
Pharmacology, Toxicology and Pharmaceutical Science
ABCG2
25%
Anthracycline
75%
Bile Salt Export Pump
25%
Cytotoxic Agent
25%
De Novo Acute Myeloid Leukemia
25%
Drug Resistance
25%
Drug Transport
50%
Epipodophyllotoxin
25%
Epitope
25%
Leukemia
100%
Long Term Survival
50%
Malignant Neoplasm
25%
Membrane Protein
25%
Multidrug Resistance Associated Protein
100%
Multidrug Resistance Associated Protein 1
100%
Multidrug Resistance Associated Protein 3
25%
Multidrug Resistance Associated Protein 4
25%
Multidrug Resistance Protein 5
25%
Multidrug Resistance-Associated Protein 2
25%
Multiple Drug Resistance
25%
P-Glycoprotein
50%
Vinca Alkaloid
25%
Biochemistry, Genetics and Molecular Biology
ABCG2
33%
Anthracycline
100%
Cancer Cell
33%
Drug Resistance
33%
Long Term Survival
66%
Membrane Protein
33%
Membrane Transport
100%
Multidrug Resistance
33%
Multidrug Resistance Associated Protein
100%
Multidrug Resistance-Associated Protein 2
33%
P-Glycoprotein
100%
Translocator Protein
66%
Transmembrane Protein
33%
Transporter Associated with Antigen Processing
33%
Upregulation
33%
Vinca
33%
Immunology and Microbiology
ABCG2
33%
Antigen Presentation
33%
Cancer Cell
33%
Drug Resistance
33%
Drug Transport
66%
Epitope
33%
Long Term Survival
66%
Membrane Transport
100%
Multidrug Resistance
33%
Multidrug Resistance Associated Protein
100%
P-Glycoprotein
100%
Upregulation
33%
Vinca
33%